Literature DB >> 18373482

Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions.

Jeanna Tsenter1, Liana Beni-Adani, Yaniv Assaf, Alexander G Alexandrovich, Victoria Trembovler, Esther Shohami.   

Abstract

Memory and neurobehavioral dysfunctions are among the sequelae of traumatic brain injury (TBI). The Neurological Severity Score (NSS) includes 10 tasks and was previously designed to assess the functional status of mice after TBI. The object recognition task (ORT) measures specific episodic memory and is expressed by the percent time spent by an animal at a novel, unfamiliar object (Discrimination Index [DI]). It is an ideal tool for evaluating cognitive function after TBI. The present study sought to validate the use of the NSS and ORT in severe and mild focal TBI in mice, and to confirm that the spontaneous recovery and the radiological abnormalities, shown by T2-weighted magnetic resonance imaging (MRI), are dependent upon injury severity. Mice were subjected to severe and mild closed head injury (NSS at 1 h 7.52 +/- 0.34 and 4.62 +/- 0.14, respectively). NSS was evaluated for 25 days and showed a decrease by 3.86 +/- 0.26 and 2.54 +/- 0.35 units in the severely and mildly injured mice, respectively. ORT revealed DI in severely injured group of 51.7 +/- 6.15%, (vs approximately 75-80% in uninjured animal) on day 3 and 66.2 +/- 6.81% on day 21. In contrast, the mildly injured mice did not show cognitive impairment throughout the same period. The damage seen by MRI at 24 h after injury, strongly correlated with NSS(1h) (R = 0.87, p < 0.001). We conclude that NSS is a reliable tool for evaluation of neurological damage in head-injured mice, NSS(1h) predicts the motor dysfunction, cognitive damage, and brain-damage characteristics as depicted by T2-weighted MRI. The combined assessment of neurobehavioral and cognitive function along with MRI is most useful in evaluating recovery from injury, especially when testing effectiveness of novel treatments or genetic manipulations.

Entities:  

Mesh:

Year:  2008        PMID: 18373482     DOI: 10.1089/neu.2007.0452

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  57 in total

1.  Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury.

Authors:  Aniv Mann; Reem Smoum; Victoria Trembovler; Alexander Alexandrovich; Aviva Breuer; Raphael Mechoulam; Esther Shohami
Journal:  J Neuroimmune Pharmacol       Date:  2015-02-27       Impact factor: 4.147

2.  The spectrum of neurobehavioral sequelae after repetitive mild traumatic brain injury: a novel mouse model of chronic traumatic encephalopathy.

Authors:  Anthony L Petraglia; Benjamin A Plog; Samantha Dayawansa; Michael Chen; Matthew L Dashnaw; Katarzyna Czerniecka; Corey T Walker; Tyler Viterise; Ollivier Hyrien; Jeffrey J Iliff; Rashid Deane; Maiken Nedergaard; Jason H Huang
Journal:  J Neurotrauma       Date:  2014-06-12       Impact factor: 5.269

3.  Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.

Authors:  Veronica Lifshitz; Ronen Weiss; Tali Benromano; Einat Kfir; Tamar Blumenfeld-Katzir; Catherine Tempel-Brami; Yaniv Assaf; Weiming Xia; Tony Wyss-Coray; Howard L Weiner; Dan Frenkel
Journal:  Neurobiol Aging       Date:  2011-03-02       Impact factor: 4.673

4.  Neuroprotection after traumatic brain injury in heat-acclimated mice involves induced neurogenesis and activation of angiotensin receptor type 2 signaling.

Authors:  Gali Umschweif; Dalia Shabashov; Alexander G Alexandrovich; Victoria Trembovler; Michal Horowitz; Esther Shohami
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-21       Impact factor: 6.200

5.  Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury.

Authors:  Lital Magid; Sami Heymann; Merav Elgali; Liat Avram; Yoram Cohen; Sigal Liraz-Zaltsman; Raphael Mechoulam; Esther Shohami
Journal:  J Neurotrauma       Date:  2019-02-07       Impact factor: 5.269

6.  D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.

Authors:  Amos Adeleye; Esther Shohami; Dean Nachman; Alexander Alexandrovich; Victoria Trembovler; Rami Yaka; Yigal Shoshan; Jasbeer Dhawan; Anat Biegon
Journal:  Eur J Pharmacol       Date:  2009-12-01       Impact factor: 4.432

7.  Argon Inhalation for 24 h After Closed-Head Injury Does not Improve Recovery, Neuroinflammation, or Neurologic Outcome in Mice.

Authors:  Jennifer Creed; Viviana Cantillana-Riquelme; Bai Hui Yan; Shuang Ma; Dongmei Chu; Haichen Wang; Dennis A Turner; Daniel T Laskowitz; Ulrike Hoffmann
Journal:  Neurocrit Care       Date:  2020-09-21       Impact factor: 3.210

8.  Long-term in vivo imaging of viscoelastic properties of the mouse brain after controlled cortical impact.

Authors:  Thomas Boulet; Matthew L Kelso; Shadi F Othman
Journal:  J Neurotrauma       Date:  2013-08-01       Impact factor: 5.269

9.  Greater neurodegeneration and behavioral deficits after single closed head traumatic brain injury in adolescent versus adult male mice.

Authors:  Fernanda Guilhaume-Correa; Shelby M Cansler; Emily M Shalosky; Michael D Goodman; Nathan K Evanson
Journal:  J Neurosci Res       Date:  2019-09-20       Impact factor: 4.164

10.  Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.

Authors:  Jan Hendrik Schaefer; Wendy Leung; Limin Wu; Elizabeth M Van Cott; Josephine Lok; Michael Whalen; Klaus van Leyen; Arne Lauer; Joanne van Ryn; Eng H Lo; Christian Foerch
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-19       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.